Assessing ST18 gene polymorphisms (rs17315309, rs2304365) in Iraqi patients with Pemphigus vulgaris
Zahra Ali Al-Hasnawi, Ban AL-Drobie

TL;DR
This study investigates the link between two ST18 gene SNPs and Pemphigus vulgaris in Iraqi patients, finding one SNP significantly associated with the disease.
Contribution
The study identifies a novel genetic association between rs17315309 A/G in the ST18 gene and Pemphigus vulgaris in the Iraqi population.
Findings
The rs17315309 A/G SNP in the ST18 gene is significantly associated with Pemphigus vulgaris in Iraqi patients.
The mutant G-allele of rs17315309 is more prevalent in PV patients compared to healthy controls.
No significant association was found between rs2304365 C/G and Pemphigus vulgaris in the same population.
Abstract
Pemphigus vulgaris (PV) is a potentially fatal autoimmune disease characterized by blistering of the skin, mucous membranes, and oral cavity. Genetics are implicated in its etiology, with the ST18 gene identified as a potential risk factor for pemphigus in certain populations, suggesting its role as a novel molecular target for therapeutic intervention. This study aimed to detect single nucleotide polymorphisms (SNPs) rs17315309 A/G and rs2304365 C/G in the ST18 gene among Iraqi/Arabic patients with PV. A total of 90 Iraqi subjects participated in this study, including 45 patients diagnosed with PV and 45 healthy controls. SNP analysis was performed using High-Resolution Melt Analysis (HRMA) with Eva Green I Dye. For SNP rs17315309 A/G, the distribution of heterozygous genotypes showed highly significant differences between the patient and healthy groups (P = 0.005), with the mutant…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Primer | Sequence (5'→3' direction) | Primer Size (bp) |
|---|---|---|
| Forward | 5’-CTTCTCGTGATTAGCATACAAA-3’ | 22 |
| Reverse | 5’-GCCAGGCAGCAATTCATTTC-3’ | 20 |
| Forward | 5’AGCTTTCCAAATTCAACCCAAGA-3’ | 23 |
| Reverse | 5’-GCAAAACTTGGAGGAAAACATGC-3’ | 23 |
| Variables | PV group | Control | ||||||
|---|---|---|---|---|---|---|---|---|
|
| % |
| % | |||||
| Age | 20–30 | 5 | 11.1 | 9 | 20 | χ2 = 9.394 | ||
| 30–40 | 6 | 13.3 | 15 | 33.3 | ||||
| 40–50 | 19 | 42.2 | 15 | 33.3 | ||||
| 50–60 | 9 | 20.0 | 4 | 8.9 | ||||
| 60–70 | 6 | 13.3 | 2 | 4.4 | ||||
| Total | 45 | 100 | 45 | 100 | ||||
| Mean ± SD | 45.36 ± 10.60 | 37.02 ± 10.49 | ||||||
| Range | 27–67 | 21–70 | ||||||
| Gender | Men | 14 | 31.1 | 14 | 31.1 | χ2 = 0.000 | ||
| Women | 31 | 68.9 | 31 | 68.9 | ||||
| Total | 45 | 100 | 45 | 100 | ||||
| C.S. (*) | χ2 = 3.411 | χ2 = 3.007 | ||||||
| SNP | Type | PV group ( | Control group ( | OR | 95% CI | ||
|---|---|---|---|---|---|---|---|
| rs17315309 | Genotype | AA (wild) | 24 (53.3%) | 7 (15.5%) | -- | 1.00 | (Reference) |
| AG (hetero) | 15 (33.3%) | 20 (44.4%) | 0.005** | 0.21 | 0.0746–0.6414 | ||
| GG (mutant) | 6 (13.3%) | 18 (40%) | 0.003* | 0.09 | 0.0279–0.3393 | ||
| Allele | A (wild) | 63 (70.00%) | 34 (37.78%) | -- | 1.00 | (Reference) | |
| G (mutant) | 27 (30.00%) | 56 (62.22%) | 0.001** | 0.2 | 0.1399–0.4839 | ||
| Number | n = 90 | n = 90 | |||||
| rs2304365 | Genotype | CC (wild) | 17 (37.8%) | 18 (40%) | -- | 1.00 | (Reference) |
| CG (hetero) | 18 (40%) | 21 (46.6%) | 0.8 | 0.9 | 0.3638–2.2642 | ||
| GG (mutant) | 10 (22.2%) | 6 (13.3%) | 0.3 | 1.7 | 0.5263–5.9172 | ||
| Allele | C (wild) | 52 (57.78%) | 57 (63.33%) | -- | 1.00 | (Reference) | |
| G (mutant) | 38 (42.22%) | 33 (36.67%) | 0.4 | 1.2 | 0.6934–2.2976 | ||
| Number | |||||||
| Symbol | Genotype | Patients group | Control group | ||||
|---|---|---|---|---|---|---|---|
| Obs. | Exp. | H-W | Obs. | Exp. | H-W | ||
| rs17315309 | Wild AA | 24 | 22.05 | 9% | 7 | 6.42 | 14.2% |
| Hetero AG | 15 | 18.9 | 42% | 20 | 21.16 | 47.01% | |
| Mutant GG | 6 | 4.05 | 49% | 18 | 17.42 | 38.72% | |
| H-W Equilibrium | |||||||
| rs2304365 | Wild C/C | 17 | 15.02 | 33.38% | 18 | 18.05 | 40.1% |
| Hetero C/G | 18 | 21.96 | 48.79% | 21 | 20.90 | 46.4% | |
| Mutant G/G | 10 | 8.02 | 17.83% | 6 | 6.05 | 13.44% | |
| H-W Equilibrium | |||||||
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAutoimmune Bullous Skin Diseases · Platelet Disorders and Treatments · Coagulation, Bradykinin, Polyphosphates, and Angioedema
INTRODUCTION
Pemphigus vulgaris (PV) is a severe autoimmune blistering disease that primarily affects the skin and mucous membranes, including the oral cavity. Genetics is believed to play a significant role in its development. The ST18 gene has emerged as a potential contributor, potentially increasing the risk of PV in certain populations, and could represent a new potential molecular target for the treatment of disease. PV is a relatively rare disease, affecting approximately 0.07 to 1.6 per 100,000 people annually, with uneven geographic distribution [1]. It has been associated with a 2.3-3.3-fold increased fatality rate compared to the general population, primarily due to complications such as pneumonia or sepsis [2]. This disease is characterized by the production of specific autoantibodies against desmogleins 1 and 3. These antibodies disrupt the adhesion between keratinocytes (skin cells), leading to acantholysis and, ultimately, blister formation. PV is diagnosed clinically and by histopathological biopsy, which may be done on the skin or oral mucosa. Biopsies of affected skin or oral mucosa are often taken for two types of analysis: direct immunofluorescence (DIF) to detect the presence of autoantibodies and histology to examine tissue samples under a microscope for characteristic features of PV [3]. Oral lesions often appear before skin involvement, affecting 80-90% of patients with PV at some point. These lesions may exist for weeks or months before the skin lesions appear. PV may sometimes affect only the oral mucosa in certain people. These lesions can manifest as shallow, irregular erosions on the inner cheeks (buccal mucosa), palate, tongue, and gums (gingiva). As the lesions heal, they may develop a more defined border and a whitish appearance before disappearing completely [4].
Growing evidence suggests a genetic influence on PV development. While the disease can affect individuals of any age or gender, epidemiological data reveals variations across populations. For instance, PV appears more prevalent in Caucasians and East Asians, while pemphigus foliaceus, another form, is more common in South America and North Africa. Age and gender predilection also appear to vary across regions, suggesting the combined influence of genetics, hormones, and environmental factors on PV and its subtypes [5]. While the human leukocyte antigen (HLA) system is known to be involved in autoimmune diseases, recent research has focused on the roles of non-HLA genes in PV. Candidate gene studies have explored potential associations between genes related to the immune system and PV, in particular autoantigens, cytokines, and immunoglobulins, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), IL-10, desmoglein 3 (DSG3), VH3, TAP2, ST18, CD86, and NR3C1 [6].
Genome-wide association studies (GWAS) have provided further insights into the genetic basis of PV. A study by Sarig et al. employing GWAS in the Jewish population identified an association between PV and polymorphisms (variations) within the ST18 gene on chromosome 8q11.23 [7]. The ST18 gene, known for its role in suppressing tumorigenicity, is involved in apoptosis and inflammation regulation, encoding a zinc-finger DNA-binding protein. These functions are crucial in the pathophysiology of PV, acting through mechanisms associated with a transcription factor directly implicated in the disease [8]. Further research highlighted that a single nucleotide polymorphism (SNP) in the ST18 promoter region, associated with PV, appears to increase gene transcription activity. Experimental evidence has shown that ST18 is activated by PV serum, leading to acantholysis (the breakdown of cellular adhesion in the skin) and the production of key inflammatory mediators. These findings underscore the direct involvement of ST18 in the pathogenesis of PV [9,10]. To our knowledge, this is the first study that aimed to determine the relationship between ST18 gene polymorphisms (rs17315309 A/G and rs2304365 C/G) and the incidence of Pemphigus vulgaris within the Iraqi population.
MATERIAL AND METHODS
Study design and population
This case-control study was conducted between April and November 2022 at the Department of Dermatology, Baghdad Teaching Hospital. We included a cohort of 90 individuals from Central Iraq, including 45 patients with clinically and histopathologically confirmed PV and 45 healthy control individuals without any history of autoimmune disorders, cancer, infectious diseases, systemic inflammation, or allergies. None of the controls were related to the patients with PV. The groups were matched for age and gender.
Blood collection
Approximately two milliliters of venous blood were collected from each participant by trained healthcare professionals. The blood was immediately transferred to tubes containing Ethylenediaminetetraacetic Acid (EDTA) and stored at low temperatures in a deep freezer [11,12].
SNPs selection
We focused on the ST18 gene located on chromosome 8q11.23 for SNP selection. We identified SNPs by reviewing previously published studies, specifically those involving the ST18 gene. Additionally, we utilized the database of Single Nucleotide Polymorphisms (dbSNP), which is a part of the National Center for Biotechnology Information (NCBI) [13].
Primer design
Primers for amplifying the selected SNPs were designed using the Primer3 Plus web service and cross-validated by the University Code of Student Conduct programs. Reference sequences were obtained from the NCBI database. Primers were synthesized and supplied in a lyophilized form by Alpha DNA (Table 1).
DNA extraction and analysis
Genomic DNA was extracted from the stored frozen blood samples using the Easy Pure Genomic DNA Kit (Transgene Biotech). The extraction process was conducted in strict accordance with the manufacturer's recommended protocol [14]. The concentration and purity of the extracted DNA were assessed using a NanoDrop spectrophotometer. Agarose gel electrophoresis was then employed to confirm the presence and quality of the isolated genomic DNA (gDNA) as well as the PCR amplification products, ensuring their suitability for further analysis [15,16].
High-Resolution Melting (HRM) analysis for genotyping
We investigated the association between the selected ST18 gene SNPs (rs17315309 A/G and rs2304365 C/G) and PV in Iraqi patients using real-time PCR with HRM analysis. The Trans Start Tip Green qPCR Super Mix (Trans Gen Biotech, AQ141-01) and Eva Green I Dye were employed.
HRM real-time PCR technique
The Rotor-Gene Q Real-Time PCR System (QIAGEN) was used for qPCR-HRM analysis. The HRM analysis involved a temperature gradient from 55°C to 95°C with an increment of 0.2°C. Duplicate reactions were performed using synthetic SNP sequences with 2xTransStart Tip Green qPCR Super Mix. Triplicate synthetic controls were subjected to qPCR-HRM to identify allelic variations. Normalized melting curves (NMC) and differential melting curves (DC) were generated using the HRM software integrated into the Rotor-Gene 4.4 software.
Statistical analysis
Data analysis was performed using the Rotor-Gene Q Series Software and included recording Ct values, amplification plots, dissociation curves, HRM curves, and a consolidated report. Further statistical analyses were conducted using SPSS for Windows, version 26. Descriptive statistics were expressed as mean ± standard deviation (SD). Genotype and allele frequencies were evaluated for Hardy-Weinberg equilibrium (HWE) [17]. A Chi-square test (χ^2^ test) was used to compare frequencies between patient and control groups, with a P value of less than 0.05 considered statistically significant.
RESULTS
This study recruited a total of 90 participants from Central Iraq. The study groups comprised 45 patients diagnosed with PV and 45 healthy controls with no history of relevant medical conditions. The socio-demographic characteristics, including age and sex distribution, are presented in Table 2. There was no significant difference in age and sex distribution between the two groups, suggesting that any deviations observed in the patient group could be attributed to the effects of PV rather than demographic disparities.
Genotype and allele frequency for SNPs rs17315309A/G and rs2304365C/G
Table 3 shows the genotype frequencies of SNPs rs17315309 and rs2304365 within the ST18 gene. Both SNPs were confirmed to be in Hardy-Weinberg equilibrium (P >0.05). For the SNP rs17315309, the hetero genotype distributions between patients and the control group showed considerable variations (OR = 0.21; 95% CI, 0. 0746–0.6414; P <0.005) and major variations in the distributions of mutant genotypes (OR = 0.09l; 95% CI, 0.0279–0.3393; P <0.003) (A/G). The patient group had considerably higher mutant G-allele frequencies than the control group (OR = 0.2; 95% CI, 0.1399–0.4839; P <0.001). For the SNP rs2304365, there were non-significant variations in the hetero genotype distributions between patients and control (OR = 0.9; 95% CI, 0.3638–2.2642; P <0.8), and non-significant differences in the mutant genotype distributions (OR = 1.7; 95% CI, 0.5263–5.9172; P <0.3) (C/G), and allele frequencies for the mutant G-allele (OR = 1.2; 95%CI, 0.6934–2.2976; P <0.4,).
Observed and expected allele frequencies
Table 4 shows the genotype distributions for SNPs rs17315309A/G and rs2304365C/G and the observed and expected allele frequencies in both the patient and control groups. This table also includes the allele frequencies anticipated under the Hardy-Weinberg Equilibrium and examines the significance of these frequencies between the groups studied. The chi-squared (χ^2^) test for HWE showed no significant difference from the expected frequencies in either patient or control groups (P > 0.05).
DISCUSSION
Our findings revealed a potential correlation between the rs17315309 polymorphism within the ST18 gene and PV risk in the Iraqi population. This is the first study to investigate this association in an Iraqi cohort, highlighting the potential for rs17315309 as a novel target for future research. However, limitations include the relatively small sample size due to the rarity of PV and the need to explore additional SNPs within the ST18 gene.
In terms of age demographics, the mean age of our patient group was 45.36 ± 10.60 years, supporting findings from previous studies conducted in Iraq (average age 46 years) [18] and India (average age 41.3 ± 13.65 years) [19]. Conversely, studies from Poland reported an average age range of 50 to 55 years (51.6 years) [20], while Japanese research indicated an average patient age of 62 years [21]. The results could be due to a difference in study sample size and ethnic variations. Regarding gender distribution, most patients in the PV and control groups were women (68.9%), and only 31.1% were men. There was no statistical difference in gender distribution (χ^2^ = 0.000 P = 1.000). This finding supports the commonly observed trend of higher susceptibility to PV in female subjects, aligning with studies from Iraq [4] and Slovakia [22]. The female prevalence of this autoimmune disease can be explained by hormonal (estrogen, progesterone), immunological, and genetic (specific genes encoded on the X chromosome) factors, which are known to modulate autoimmune responses, particularly during periods of hormonal fluctuation like pregnancy and postpartum. The estrogen hormone may play a major role in increasing PV incidence among females since this hormone has been reported to enhance immunological reactions [23].
Our investigation revealed a significant association between SNP rs17315309 in the ST18 gene and PV among the Iraqi population, supporting the findings of Vodo et al. [9] from the 2016 Tel-Aviv study. They reported that rs17315309 significantly increased the risk for PV within the Jewish community, a finding that aligns with our observations. This SNP was discovered to promote higher gene transcription in a p53/p63-dependent manner, which might explain why ST18 is upregulated in PV patients' skin [9]. Our results are further supported by Assaf et al., who identified an overexpression of the ST18 gene associated with rs17315309 in the skin of patients with PV [24]. This overexpression is implicated in the release of inflammatory cytokines and PV IgG-induced acantholysis of keratinocytes, with a particular emphasis on the role of TNFα. Elevated levels of TNFα, previously detected in the serum of patients with PV, may exacerbate the disease, suggesting that increased TNFα production could act as a pathway for the detrimental effects of ST18 in PV pathogenesis [24]. However, this result disagrees with another study, which included the Italian Caucasian population and observed an increased presence of the risk allele in control subjects compared to PV patients for rs17315309. This highlights the complex interplay of genetic factors and suggests potential ethnic-specific influences on the disease's genetic predisposition [10].
The genotype and allele frequencies for SNP rs2304365 presented in our study did not show a significant relationship with PV in the Iraqi cohort. This finding aligns with previous studies. For instance, a study by Sarig et al. observed no significant association between this SNP and PV in a Jewish population of German descent [7]. Similarly, research by Yue et al. [25] found no relationship between rs2304365 and PV in a Han Chinese population. These findings suggest that the contribution of ST18-related polymorphisms to PV susceptibility may vary between populations, reinforcing the concept that genetic risk factors for PV can be highly population-specific.
Minor allele frequency (MAF) analysis of rs2304365 revealed significant variations across populations: African (0.402), European (0.208), and Han Chinese (0.119) from Beijing. The significant difference in MAF between African and other populations may point towards a unique evolutionary trajectory, potentially explaining why a connection was observed only within the African cohort but not among German or Chinese descent. [25]. Additionally, this contrasts with a study from Tehran by Etesami et al., which found a significant correlation between SNP rs2304365 and PV in the Iranian population. Their results suggested that the risk allele might lead to an overexpression of ST18, prompting keratinocytes to release cytokines. This process could facilitate the onset of pemphigus by increasing the vulnerability of keratinocytes to IgG-mediated cell-cell detachment [11].
CONCLUSION
This study identified an association between PV and the SNPs rs17315309 A/G within the ST18 gene among the Iraqi population of Arab origin. However, there was no association between PV and the SNPs rs2304365 C/G. To completely understand the relevance of the ST18 gene in Iraqi patients with PV, more replication studies within varied genetic backgrounds are required.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Alshami ML Aswad F Abdullah B Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris Pan African Medical Journal 20224210.11604/pamj.2022.42.186.35429 PMC 950837236212929 · doi ↗ · pubmed ↗
- 2Rashid H Lamberts A Diercks GFH Pas HH Meijer JM Bolling MC Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm Am J Clin Dermatol 201920684786110.1007/s 40257-019-00461-731313078 PMC 6872602 · doi ↗ · pubmed ↗
- 3Glick M Greenberg MS Lockhart PB Challacombe SJ Introduction to Oral Medicine and Oral Diagnosis: Patient Evaluation Burket’s Oral Medicine 202111810.1002/9781119597797.ch 1 · doi ↗
- 4Alshami ML Aswad F Abdullah BA clinical and demographic analysis of oral pemphigus vulgaris: A retrospective cross-sectional study from 2001 to 2021 Health Sci Rep 202255 e 83210.1002/hsr 2.83236172301 PMC 9470012 · doi ↗ · pubmed ↗
- 5Alpsoy E Akman-Karakas A Uzun S Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid Arch Dermatol Res 20153074291810.1007/s 00403-014-1531-125589418 · doi ↗ · pubmed ↗
- 6Vodo D Sarig O Sprecher E The Genetics of Pemphigus Vulgaris Front Med (Lausanne)2018522610.3389/fmed.2018.0022630155467 PMC 6102399 · doi ↗ · pubmed ↗
- 7Sarig O Bercovici S Zoller L Goldberg I Indelman M Nahum S Population-specific association between a polymorphic variant in ST 18, encoding a pro-apoptotic molecule, and pemphigus vulgaris J Invest Dermatol 20121327179880510.1038/jid.2012.4622437316 · doi ↗ · pubmed ↗
- 8Yang J Siqueira MF Behl Y Alikhani M Graves DT The transcription factor ST 18 regulates proapoptotic and proinflammatory gene expression in fibroblasts FASEB J 2008221139566710.1096/fj.08-11101318676404 PMC 2574028 · doi ↗ · pubmed ↗
